NeuroEM Therapeutics | WebDisclosure

Basculer en Français

10965	Companies
240121	Keywords
168886	Articles
129213	Press releases

Home
Companies
NeuroEM Therapeutics

BRIEF

published on 09/19/2024 at 14:35, 1 year 11 months ago

NeuroEM Therapeutics Accepted into StartUp Health's Alzheimer's Moonshot Community

NeuroEM Therapeutics Alzheimer's Moonshot Transcranial Electromagnetic Treatment Gates Ventures ADDF
BRIEF

published on 09/19/2024 at 14:35, 1 year 11 months ago

NeuroEM Therapeutics a été acceptée dans la communauté Alzheimer's Moonshot de StartUp Health

Gates Ventures ADDF Thérapeutique NeuroEM La Mission Lunaire Contre La Maladie D'Alzheimer Traitement Électromagnétique Transcrânien
PRESS RELEASE

published on 09/19/2024 at 14:30, 1 year 11 months ago

NeuroEM Therapeutics(R) Accepted into StartUp Health's Alzheimer's Moonshot Community(TM)
NeuroEM Therapeutics joins StartUp Health's Alzheimer's Moonshot Community to accelerate innovation in Alzheimer's care. Cutting-edge TEMT-RF technology aims to prevent and treat cognitive decline

NeuroEM Therapeutics StartUp Health Alzheimer's Moonshot Community TEMT-RF Technology Cognitive Decline
PRESS RELEASE

published on 11/16/2023 at 19:30, 2 years 9 months ago

NeuroEM Therapeutics Emerges from Chapter 11 with a Stronger Vision, New Leadership, and Renewed Focus on Growth

Accesswire

Published on 09/11/2026 at 17:00, 3 hours 13 minutes ago

Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 17:00, 3 hours 13 minutes ago

Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan
Published on 09/11/2026 at 15:25, 4 hours 48 minutes ago

Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 15:00, 5 hours 13 minutes ago

Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 14:30, 5 hours 43 minutes ago

AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value

View all ACCESSWIRE

EQS Group

Published on 09/11/2026 at 19:44, 28 minutes ago

DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 1 hour 58 minutes ago

CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 18:07, 2 hours 6 minutes ago

Holding(s) in Company
Published on 09/11/2026 at 18:06, 2 hours 6 minutes ago

Cairn Homes Plc: Holding(s) in Company
Published on 09/11/2026 at 18:00, 2 hours 13 minutes ago

ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL

Les Echos

Published on 09/11/2026 at 07:00, 13 hours 13 minutes ago

Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 13 hours 13 minutes ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 13 hours 13 minutes ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 13 hours 13 minutes ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day ago

Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE